CatalystFDA/Bio

VERA THERAPEUTICS, INC. (VERA) DISCUSSES ACCELERATED FDA APPROVAL OF TRUTAKNA FOR IGA NEPHROPATHY TRANSCRIPT - SEEKINGALPHA

Accelerated FDA approval for IgA nephropathy is a major regulatory catalyst.

What changed

Why it matters

Accelerated FDA approval for IgA nephropathy is a major regulatory catalyst.

Sources